GR74627B - - Google Patents
Info
- Publication number
- GR74627B GR74627B GR65799A GR810165799A GR74627B GR 74627 B GR74627 B GR 74627B GR 65799 A GR65799 A GR 65799A GR 810165799 A GR810165799 A GR 810165799A GR 74627 B GR74627 B GR 74627B
- Authority
- GR
- Greece
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17935880A | 1980-08-18 | 1980-08-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR74627B true GR74627B (en:Method) | 1984-06-29 |
Family
ID=22656255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR65799A GR74627B (en:Method) | 1980-08-18 | 1981-08-14 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0046290B1 (en:Method) |
| JP (1) | JPS5759812A (en:Method) |
| AU (1) | AU7398381A (en:Method) |
| DD (1) | DD200404A5 (en:Method) |
| DE (1) | DE3168036D1 (en:Method) |
| FI (1) | FI812469A7 (en:Method) |
| GR (1) | GR74627B (en:Method) |
| PT (1) | PT73517B (en:Method) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4447443A (en) * | 1982-11-15 | 1984-05-08 | Merck & Co., Inc. | Anti-inflammatory/analgesic combination of α-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (NSAID) |
| US5030645A (en) * | 1990-10-15 | 1991-07-09 | Merck & Co., Inc. | Method of treating asthma using (S)-α-fluoromethyl-histidine and esters thereof |
| FR2822709B1 (fr) * | 2001-03-30 | 2007-01-19 | Antialis | Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique |
| FR2896156A1 (fr) * | 2006-01-17 | 2007-07-20 | Gaetan Terrasse | Nouvelle utilisation de la tritoqualine en association avec des substances medicamenteuses antagonistes du recepteur h2 a l'histamine,pour le traitement des maladies inflammatoires digestives |
| EP2170317A4 (en) * | 2007-02-12 | 2011-03-23 | Mike Nicolaou | TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), GASTRO-OESOPHAGEAL REFLUX DISEASE (GERD), FOOD ALLERGIES, AND OTHER DISEASES AND GASTROINTESTIN DISORDERS AFFECTED BY APPROPRIATE MANAGEMENT OF HISTAMINE USING A COMBINATION OF INHIBITORS HISTIDINE DECARBOXYLASE, MEDICAMEN |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4000302A (en) * | 1972-04-20 | 1976-12-28 | Smith Kline & French Laboratories Limited | Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors |
| US4215221A (en) * | 1977-06-01 | 1980-07-29 | Merck & Co., Inc. | Fluorination process |
-
1981
- 1981-08-10 FI FI812469A patent/FI812469A7/fi not_active Application Discontinuation
- 1981-08-11 AU AU73983/81A patent/AU7398381A/en not_active Abandoned
- 1981-08-13 DD DD81232586A patent/DD200404A5/de unknown
- 1981-08-13 PT PT73517A patent/PT73517B/pt unknown
- 1981-08-14 GR GR65799A patent/GR74627B/el unknown
- 1981-08-17 DE DE8181106371T patent/DE3168036D1/de not_active Expired
- 1981-08-17 EP EP81106371A patent/EP0046290B1/en not_active Expired
- 1981-08-18 JP JP56128291A patent/JPS5759812A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE3168036D1 (en) | 1985-02-14 |
| AU7398381A (en) | 1982-02-25 |
| PT73517A (en) | 1981-09-01 |
| EP0046290A1 (en) | 1982-02-24 |
| JPH0154326B2 (en:Method) | 1989-11-17 |
| DD200404A5 (de) | 1983-05-04 |
| FI812469L (fi) | 1982-02-19 |
| JPS5759812A (en) | 1982-04-10 |
| FI812469A7 (fi) | 1982-02-19 |
| PT73517B (en) | 1983-07-06 |
| EP0046290B1 (en) | 1985-01-02 |